Tuesday, October 21, 2025 from 8:30 a.m. to 10:00 a.m. CDT at Greenway FGHIJ, 2nd Floor
This session is being recorded.
Learn MoreAvailable for 1.50 hours of CPE creditActivity Number: 0217-0000-25-114-L01-PActivity Type: An Application-Based ActivityDose-adjusting medications for chronic or acute kidney impairment is critical to maintain efficacy and mitigate the toxicity of many medications. Pharmacists face challenges in choosing best practices for determining kidney function and estimating this appropriately in the setting of acute changes in hemodynamic status. This session will examine updates such as removing race from equations for estimating kidney function and transitioning to the use of eGFR for drug-related decision-making and how these concepts influence patient care. Case-based scenarios will be presented throughout to examine the best ways to dose medications eliminated via the kidneys.
Learning Objectives1. Describe the evolution of kidney function estimation equations including rationale for the development of non-race-based estimated glomerular filtration rate (eGFR) equations.
2. Interpret the rationale, recommendations, and supporting evidence for using non-race-based eGFR equations rather than eCrCl (Cockcroft-Gault (C-G) equation) for drug-related decisions.
3. Examine various methods for estimating eGFR for drug-related decision-making.
4. Select the most appropriate eGFR equation for drug dosing depending on the clinical scenario.
5. Formulate a plan to best implement the change from the Cockcroft-Gault (C-G) eCrCl equation to the CKD-EPI eGFR equations for drug dosing within your pharmacy practice.
 | | Moderator: | Sheryl F. Vondracek, Pharm.D., FCCP, BCPS | | Associate Professor
Skaggs School of Pharmacy and Pharmaceutical Sciences
University of Colorado Anschutz Medical Campus
Aurora, Colorado | | View Biography |
|
From Nephron to Numbers: Unraveling the Evolution of Kidney Function Estimates8:30 a.m. to 9:15 a.m. | | Speaker: | Andrew S. Bzowyckyj, Pharm.D., FCCP, FAPhA, FADCES, CDCES | | Senior Scientific Director, Learning Consultant
National Kidney Foundation
New York, New York | | View Biography |
|
|
eGFR for Drug Dosing - The New Frontier9:15 a.m. to 10:00 a.m. | | Speaker: | Tracy Anderson-Haag, Pharm.D., BCPS, BCTXP | | Clinical Pharmacy Specialist-Transplantation
Residency Program Director, PGY-2 Solid Organ Transplant
Hennepin Healthcare
Minneapolis, MN
and
Adjunct Associate Professor
University of Minnesota, College of Pharmacy
Minneapolis, MN
| | View Biography |
|
|